The French drugmaker, whose pursuit of Genzyme and its portfolio of lucrative, high price drugs has turned acrimonious in recent months, told Reuters the Hart-Scott Rodino antitrust waiting period had expired.
The expiry clears the way for Sanofi to continue its efforts to convince Genzyme shareholders of the benefits of the proposed of a takeover.
In other news, Sanofi has been caught up in the widespread strike action currently sweeping Frend industry.
According to a Bousier report, Sanofi employees belonging to the CGT union blockaded the firm’smanufacturing facility in Romainville.
A CGT spokesman told the newswire that Sanofi “has refused to consider proposals for continuation of activities and jobs on the site."